Meaghan Loy, MS, ALAT, SOT Associate Member and Category Director of In Vivo Services at Scientist.com reflects on a recent 3-part webinar series focusing…

“Innovation” is suddenly the word on everybody’s lips.  Pfizer launched “Centers for Therapeutic Innovation”, Johnson and Johnson followed with their “Innovation Centres” and…

The increasing awareness of the scientific research community on the importance of open access and open science has given rise to a new…

Use of CROs in research and drug development in increasing.  ADDF shared their recommendations for navigating CRO selection 1.  We’ve summarized their insights…

Contract research organizations (CROs) often have experience overseeing all aspects of a drug development program.  ADDF recently shared their insights on navigating CRO…